Objective To explore the poor prognostic factors of patients with cervical stump carcinoma, aiming to provide certain reference for the clinical diagnosis and treatment. Methods Clinical data of 48 patients with cervical stump carcinoma admitted to the Affiliated Tumor Hospital of Xinjiang Medical University from January 1, 2005 to December 1, 2016 were retrospectively analyzed. A total of 19 patients (40%) withⅠA-ⅡA stage cervical stump carcinoma were treated with surgery+ adjuvant therapy and 29 patients (60%) in ⅡB-Ⅳ stage received radiotherapy combined with chemotherapy. The median age of onset was 51 years old. Uterine fibroids were the main cause of subtotal hysterectomy. The average time interval from subtotal hysterectomy to definite diagnosis was 10.76 years. Results The 1-,3-,5-year survival rate was 98%,83% and 74%,respectively. Univariate analysis demonstrated the time interval from subtotal hysterectomy (P=0.016), tumor diameter (P=0.016), clinical stage (P=0.036), histological grade (P=0.009),lymph node metastasis (P=0.044), parametrial invasion (P=0.046), myelosuppression (P=0.013) and radical surgery (P=0.019) were the poor prognostic factors of cervical stump carcinoma. Conclusions Poor prognosis of patients with cervical stump carcinoma is correlated with tumor diameter, clinical stage, histological grade, lymph node metastasis, parametrial invasion and myelosuppression. Histological grade is an independent risk factor.
Mu Yesai,Ayinuer·Seyiti,Gulina·Kuerban. Analysis of the poor prognostic factors affecting 48 cases of cervical stump carcinoma[J]. Chinese Journal of Radiation Oncology, 2019, 28(11): 840-842.
[1] Hellström AC,Sigurjonson T,Pettersson F. Carcinoma of the cervical stump. The radiumhemmet series 1959-1987. Treatment and prognosis[J]. Acta Obstet Gynecol Scand,2001,80(2):152-157.
[2] 周碧芳,曲军卫,周学惠,等. 宫颈残端癌的手术治疗(附 16例报告)[J]. 南京医科大学学报(自然科学版),2012(07):161-162.
Zhou BF,Qu JW,Zhou XH,et al. Surgical treatment of cervical stump carcinoma (report of 16 cases)[J]. Acta Acad Med Nanjing,2012(07):161-162.
[3] 唐珉. 宫颈癌流行病学及高危因素研究进展[J]. 中西医结合心血管病电子,2017(20):18-19. DOI:10.3969/j.issn.2095-6681.2017.20.012.
Tang M. Advances in cervical epidemiology and risk factors[J]. Cardio Disease J Integrated traditional Chin West Med,2017(20):18-19. DOI:10.3969/j.issn.2095-6681.2017.20.012.
[4] 曾婷,袁志平,刁鹏,宫颈残端癌综合治疗效果及预后分析[J]. 西北国防医学杂志,2018(6):386-389. DOI:10.16021/j.cnki.1007-8622.2018.06.009.
Zeng T,Yuan ZP,Diao P. Efficacy and prognosis of comprehensive treatment for cervical stump carcinoma[J]. Med J Nat Defend Forc Northwest Chin,2018(6):386-389. DOI:10.16021/j.cnki.1007-8622.2018.06.009.
[5] 黄运兰,袁勇. 达芬奇机器人与腹腔镜手术治疗宫颈残端癌的对比研究[J]. 中华腔镜外科杂志,2018,11(2);113-116. DOI:10.3877/cma.j.issn.1674-6899.2018.02.012.
Huang YL,Yuan Y. A contrast analysis of Da Vinci robotic and laparoscopic surgery comparative for the treatment of cervical stump cancer[J]. Chin J Laparoscop Surg (elect edit),2018,11(2);113-116. DOI:10.3877/cma.j.issn.1674-6899.2018.02.012.
[6] Ahmed H,El-Hadaad H,Abozeed WN. Survival and prognostic factors in patients with carcinoma of cervical stump[J]. J Cancer Ther,2015,10(6):1008-1021. DOI:10.4236/jct.2015.611109.
[7] Shen Z,Zhou Y,Cheng Y,et al.Retrospective analysis of surgery for cervica lstump carcinoma at early stage[J]. Mol Oncol,2018,8(2):352-355. DOI:10.3892/mco.2017.1517.